Compare Humana Inc (HUM) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs TotalEnergies SE — how do they compare? Humana Inc trades at $433 (market cap $46.49B), while TotalEnergies SE trades at $86.42 (market cap $191.82B). The key difference: TotalEnergies SE is far larger — about 4.1× Humana Inc's market cap, and TotalEnergies SE pays the higher dividend (4.93%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and TotalEnergies SE for 90 Days on average.
| HUM | TTE | |
|---|---|---|
Market Cap | $46.49B | $191.82B |
Volume | 2,567,704 | 3,311,339 |
Sector | Health | Energy |
52-Week High | $409.85 | $93.60 |
52-Week Low | $163.67 | $57.39 |
Typical Hold Time | 51 Days | 90 Days |
Enterprise Value | $53.84B | $222.81B |
Dividend Yield | 0.91% | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
TotalEnergies SE (TTE) trades at $86.11, up 2.23% today, with a bearish technical signal but strong fundamentals including a P/E of 10.77 and net income margin of 9.08%. Recent earnings show beats in Q1 and Q2 2026, while Q4 2025 missed expectations. The company announced a $10 billion investment in Argentina and increased share buybacks to $2.5 billion, signaling growth commitment amid stable cash flows.
The outlook is positive with a consensus price target of $95.33, representing 10.7% upside, supported by 55.88% analyst buy ratings. Risks include revenue declines from $263.3B in 2022 to $182.3B in 2025 and geopolitical exposure, but diversification and dividend growth plans offer resilience for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
